Literature DB >> 1467135

Effects of leukotrienes C4 and D4 on human isolated saphenous veins.

S P Allen1, A H Chester, P J Piper, A P Sampson, E S Akl, M H Yacoub.   

Abstract

1. Vascular injury during the intra-operative procedures of bypass surgery may be the initiating event in the gradual deterioration in the patency of the graft. Adhesion of leukocytes to the vascular endothelium frequently accompanies preparation and insertion of the graft. However, little is known about the effects of vasoactive substances released from leukocytes on vein graft performance. 2. To determine whether leukotrienes are capable of affecting the tone of blood vessels used as coronary artery bypass grafts we studied the human saphenous vein as intact rings using an isolated organ bath technique. 3. LTC4 and LTD4 caused weak endothelium-dependent relaxations at lower concentrations (1 pM to 1 nM) and powerful endothelium-independent contractions at higher concentrations (3 nM to 0.1 microM). The maximum responses to LTC4 and LTD4 for relaxations were 21.1 +/- 4.8% and 28.6 +/- 3.4% (% of noradrenaline induced tone) respectively and 64.6 +/- 9.9% and 59.1 +/- 7.9% (% response to KCl) respectively for contractions. 4. The inhibitor of nitric oxide formation, L-NG-monomethyl L-arginine, prevented the relaxations to LTD4, but not LTC4 and unmasked endothelium-dependent contractions to LTD4 (32.9 +/- 11.3%). NG-monomethyl L-arginine had no effect on the contractions produced by LTC4 or LTD4. 5. Indomethacin augmented relaxations and contractions of saphenous vein to LTC4 from 22.5 +/- 5.6 to 40.02 +/- 8.7 (P < 0.05) and 48.8 +/- 5.5% to 74.7 +/- 7.6% (P < 0.01) respectively. LTD4 responses were not affected by indomethacin treatment. 6. In conclusion, leukotrienes mediate biphasic responses in the human saphenous vein.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1467135      PMCID: PMC1381469     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  33 in total

1.  Platelet adhesion, release and aggregation in flowing blood: effects of surface properties and platelet function.

Authors:  H R Baumgartner; R Muggli; T B Tschopp; V T Turitto
Journal:  Thromb Haemost       Date:  1976-02-29       Impact factor: 5.249

2.  Action of dopamine on isolated human saphenous veins.

Authors:  A Hughes; P Inkpen; P Sever
Journal:  J Cardiovasc Pharmacol       Date:  1988-03       Impact factor: 3.105

3.  Leukotrienes potentiate the effects of epinephrine and thrombin on human platelet aggregation.

Authors:  P Mehta; J Mehta; D Lawson; I Krop; L G Letts
Journal:  Thromb Res       Date:  1986-03-01       Impact factor: 3.944

4.  Effects of the leukotrienes on the vasculature and blood pressure of different species.

Authors:  B A Berkowitz; B Zabko-Potapovich; R Valocik; J G Gleason
Journal:  J Pharmacol Exp Ther       Date:  1984-04       Impact factor: 4.030

Review 5.  Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.

Authors:  V Fuster; J H Chesebro
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

6.  Indomethacin and LY171883 modify porcine cardiopulmonary responses to leukotrienes.

Authors:  N C Olson; L N Fleisher
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1989-03       Impact factor: 4.006

7.  Studies on the mechanism of leukotriene induced coronary artery constriction.

Authors:  D M Roth; A M Lefer
Journal:  Prostaglandins       Date:  1983-10

8.  Leukotriene C promotes prostacyclin synthesis by human endothelial cells.

Authors:  E B Cramer; L Pologe; N A Pawlowski; Z A Cohn; W A Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Effects of local anaesthetics on responses of human saphenous vein and bovine coronary artery to neurotransmitters, acetylcholine, noradrenaline and 5-hydroxytryptamine.

Authors:  F A Wali
Journal:  Gen Pharmacol       Date:  1986

10.  Endothelium-derived relaxing factor and protection against contractions induced by histamine and serotonin in the human internal mammary artery and in the saphenous vein.

Authors:  Z H Yang; D Diederich; K Schneider; R Siebenmann; P Stulz; L von Segesser; M Turina; F R Bühler; T F Lüscher
Journal:  Circulation       Date:  1989-10       Impact factor: 29.690

View more
  4 in total

1.  Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein.

Authors:  J E Barker; Y S Bakhle; J Anderson; T Treasure; P J Piper
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Influence of endothelium and surgical preparation on responses of human saphenous vein and internal thoracic artery to angiotensin II.

Authors:  J E Barker; J Anderson; T Treasure; P J Piper
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

3.  Leukotriene receptors on human pulmonary vascular endothelium.

Authors:  J L Ortiz; I Gorenne; J Cortijo; A Seller; C Labat; B Sarria; T S Abram; P J Gardiner; E Morcillo; C Brink
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

4.  Contraction of guinea pig inferior vena cava by eicosanoids.

Authors:  L E Rinkema; C R Roman; E L VanAlstyne; S M Spaethe; J H Fleisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.